guaifenesin and pseudoephedrine hydrochloride

Generic: guaifenesin and pseudoephedrine hydrochloride

Labeler: walgreen company
NDC Directory HUMAN OTC DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name guaifenesin and pseudoephedrine hydrochloride
Generic Name guaifenesin and pseudoephedrine hydrochloride
Labeler walgreen company
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

guaifenesin 600 mg/1, pseudoephedrine hydrochloride 60 mg/1

Manufacturer
WALGREEN COMPANY

Identifiers & Regulatory

Product NDC 0363-0077
Product ID 0363-0077_23bd928b-a15a-4da4-80c3-c599113f8376
Product Type HUMAN OTC DRUG
Marketing Category NDA
Application Number NDA021585
Listing Expiration 2026-12-31
Marketing Start 2017-08-01

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03630077
Hyphenated Format 0363-0077

Supplemental Identifiers

RxCUI
1305603
UNII
495W7451VQ 6V9V2RYJ8N
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name guaifenesin and pseudoephedrine hydrochloride (source: ndc)
Generic Name guaifenesin and pseudoephedrine hydrochloride (source: ndc)
Application Number NDA021585 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
  • 60 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 CARTON (0363-0077-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
  • 2 BLISTER PACK in 1 CARTON (0363-0077-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
source: ndc

Packages (2)

Ingredients (2)

guaifenesin (600 mg/1) pseudoephedrine hydrochloride (60 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "23bd928b-a15a-4da4-80c3-c599113f8376", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["310d14be-e7ea-44b8-8b04-cffa39440d50"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["WALGREEN COMPANY"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (0363-0077-18)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0363-0077-18", "marketing_start_date": "20170801"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (0363-0077-36)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0363-0077-36", "marketing_start_date": "20170801"}], "brand_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "product_id": "0363-0077_23bd928b-a15a-4da4-80c3-c599113f8376", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "0363-0077", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "WALGREEN COMPANY", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Pseudoephedrine Hydrochloride", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "NDA021585", "marketing_category": "NDA", "marketing_start_date": "20170801", "listing_expiration_date": "20261231"}